Breathe Well Live Well
|
Invion repurposes blood pressure drug to target asthma
Australian Life Scientist Invion repurposes blood pressure drug to target asthma. Nadolol is known for its role in treating blood pressure, but now Invion is conducting a phase II trial to assess its effects on asthma and chronic bronchitis. Tim Dean (Australian Life Scientist … |
View full post on asthma – Google News
|
Global network to target asthma
South Asia Mail (CNS): A world without asthma is the ultimate vision of the Global Asthma Network (GAN), launched last week at the University of Auckland. The network aims to improve care for people with asthma around the world. Its work will range from research into … |
View full post on asthma – Google News
|
Global network to target asthma
The FINANCIAL 08/12/2012 02:48 (00:01 minutes ago). The FINANCIAL — A world without asthma is the ultimate vision of the Global Asthma Network (GAN), launched last week at the University of Auckland. Email. Print. TwitterFacebookMySpace. DelicousStumbleDigg … |
View full post on asthma – Google News
|
Global network to target asthma launches
Voxy A world without asthma is the ultimate vision of the Global Asthma Network (GAN), launched last week at the University of Auckland. The network aims to improve care for people with asthma around the world. Its work will range from research into the … |
View full post on asthma – Google News
|
Global network to target asthma
Media For Freedom A world without asthma is the ultimate vision of the Global Asthma Network (GAN), launched last week at the University of Auckland. The network aims to improve care for people with asthma around the world. Its work will range from research into the … |
View full post on asthma – Google News
|
Global network to target asthma
Asian Tribune A world without asthma is the ultimate vision of the Global Asthma Network (GAN), launched last week at the University of Auckland. The network aims to improve care for people with asthma around the world. Its work will range from research into the … |
View full post on asthma – Google News
|
Asthma: Single Target, Double Blow
Genetic Engineering News A recently identified calcium activated chloride channel (CaCC) in the airway surface epithelium and airway smooth muscle (ASM) cells of asthma patients could represent a target for reducing the excess mucus production and ASM hyperresponsiveness that … |
View full post on asthma – Google News
|
Blocking Single Target Deals Asthma a Double Blow
Genetic Engineering News A recently identified calcium activated chloride channel (CaCC) in the airway surface epithelium and airway smooth muscle (ASM) cells of asthma patients could represent a target for reducing the excess mucus production and ASM hyperresponsiveness that … |
View full post on asthma – Google News
 IBTimes.co.uk |
Immune signals may be target for asthma
Futurity: Research News Asthma is often triggered by an immune response mounted against an inhaled allergen, which leads to inflammation or swelling in the airways. The new research highlights the connection between Th17 and airway remodeling in asthma, which involves … Sleepyheads with Asthma? Cells That Damage Lungs and Cause Asthma Identified American Lung Association in Michigan Stresses Back-to-School Checklist for … |
View full post on asthma – Google News
|
$3m for Vectura as asthma target advances
Cabume – Cambridge technology news Vectura has achieved a major milestone in its asthma drug target, triggering a $3m (£1.9m) payment from its unnamed US-based pharmaceutical partner and sending its share price up 5.9 per cent to 76.25p a share. That means Vectura is still on for a … Vectura updates on developmental products and milestones |
View full post on asthma – Google News